V

Verastem
D

VSTM

7.42000
USD
-0.13
(-1.66%)
Post Trading·7.50000USD+0.08000(+1.08%)
حجم التداول
122,667
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
671,980,732
أصول ذات صلة المقالات
المزيد

العنوان: Verastem

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.